Stocks · Health care · Biological Products, (No Diagnostic Substances)

Beam Therapeutics Inc.

BEAM Clue Score48
United States Fiscal year ends December CIK 0001745999 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

By person

7 insiders · 2 transactions
36.5×

John Evans holds 36.5 times base salary in stock. $27.59M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John Evans last reported holding, valued at $23.98, the price Common Stock was last bought or sold at on the open market here, on 16 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
John M. Evans
CEO
—
$1.19M (2) scheduled
−$1.19M
1,150,205
1.11%
$27.59M
+7.2%
Fmr LLC entity
10% owner
—
—
—
854,583
0.8274%
$20.50M
−64.7%
Giuseppe Ciaramella
President
—
—
—
253,911
0.2458%
$6.09M
−10.5%
Christine Bellon
Chief Legal Officer
—
—
—
109,711
0.1062%
$2.63M
+5.3%
Sravan Kumar Emany
Chief Financial Officer
—
—
—
105,456
0.1021%
$2.53M
—
Amy Simon
Chief Medical Officer
—
—
—
85,696
0.0830%
$2.06M
+23.3%
Bethany J Cavanagh
SVP, Finance and Treasurer
—
—
—
50,984
0.0494%
$1.22M
+14.5%